Skip to main content

Search This Blog

Prostate Cancer

Posts

Male Breast Cancer: What patients should know about

Get link
Facebook
X
Pinterest
Email
Other Apps

- November 01, 2026

Invalid Access Key! Invalid Access Key!

A Patient’s Guide to Breast Cancer

Get link
Facebook
X
Pinterest
Email
Other Apps

- November 01, 2026

Invalid Access Key! Invalid Access Key!

What is bilateral breast cancer?

Get link
Facebook
X
Pinterest
Email
Other Apps

- November 01, 2026

Invalid Access Key! Invalid Access Key!

Post-Prostatectomy Radiation Therapy: Patient Selection, Timing, Imaging, and Therapy Intensification

Get link
Facebook
X
Pinterest
Email
Other Apps

- October 31, 2026

Invalid Access Key! Invalid Access Key!

A note from history: Landmarks in history of cancer, part 5

Get link
Facebook
X
Pinterest
Email
Other Apps

- October 28, 2026

Invalid Access Key! Invalid Access Key!

12 Rare Cancers: Symptoms, Treatment, and Outlook

Get link
Facebook
X
Pinterest
Email
Other Apps

- October 28, 2026

Invalid Access Key! Invalid Access Key!

10 things to know about neuroendocrine tumors

Get link
Facebook
X
Pinterest
Email
Other Apps

- October 27, 2026

Invalid Access Key! Invalid Access Key!

Powered by Blogger

Theme images by billnoll

Popular Posts

Switching Immune Cells From “Protect” to “Attack” Mode To Treat Prostate Cancer - Technology Networks

- July 03, 2020

Drugs that can ‘reprogramme’ immune cells from protecting cancer to attacking it could be an effective new treatment for some men with advanced prostate cancer, a new study shows. Researchers found that immune cells called macrophages, already drawn into prostate cancer tumours to help promote growth, can be targeted and rewired to attack the disease. In studies of cancer cells and mice with prostate cancer a so-called CXCR2 inhibitor, which blocks a protein receptor on macrophages, inhibited tumour growth by switching them from helping the tumour to triggering anti-tumour immune responses instead. The drug, called AZD5069, is now being studied in a clinical trial led by researchers at The Institute of Cancer Research and our partner hospital The Royal Marsden NHS Foundation Trust, to test its effectiveness in men with advanced prostate cancer. The new research, published in the journal published in the journal Cell Reports , was carried out by a Eur...

Tips to be fit: Should you get prostate cancer screening? - The Philadelphia Tribune

- February 24, 2020

Recent news article have suggested that healthy men don’t need to have routine prostate screenings. At first you might say, “Well I’m healthy. Maybe I’ll skip it this time.” Should you? A few years ago the United States Preventive Services Task Force said in a report that routine “prostate-specific antigen” (PSA) screenings does not save lives. Their conclusion was based on five major clinical studies. The two largest studies conducted in the U.S. and Europe found that the death rates of men who got prostate screenings were virtually the same as those who didn’t. Is this reason enough not to have a routine prostate screenings? What most people and even some doctors don’t understand is that a PSA screening is not a specific test for cancer. It’s a test that can detect abnormalities. It doesn’t identify a particular problem. One doctor put it this way “A PSA screening is like an engine warning light. When it flashes, you can’t tell if a particular spark plug is bad. It tells you on...

Man With Prostate Cancer Placing His Beliefs on Power of Olive Oil - The Pappas Post

- March 26, 2019

Genotype linked to shorter survival in metastatic prostate cancer - Urology Times

- March 02, 2020

Inheriting the adrenal-permissive HSD3B1(1245C) genotype is associated with worse outcomes in low-volume metastatic prostate cancer and might someday help identify patients who could benefit from escalated therapy, according to a recent study. In essence, some patients are genetically predisposed to having their prostate cancers make their own potent androgens, such as testosterone or dihydrotestosterone (DHT), from non-testicular sources, according to study author Nima Sharifi, MD, of Cleveland Clinic Genitourinary Malignancies Research Center, Cleveland. “This comes from germline inheritance of an effectively ‘fast’ enzyme by the gene HSD3B1 that allows for prostate cancer to make these androgens. What this means clinically is that men with low-volume metastatic prostate cancer who inherit this fast form of HSD3B1 treated with medical or surgical castration progress more quickly and have shorter survival compared with men who do not inherit this fast enzyme,” Dr. Sharifi said. Re...

Bayer, Orion prep challenge in prostate cancer market - PMLiVE

- February 18, 2019

Bayer and Orion have put some meat on the bones of their phase 3 trial of darolutamide in non-metastatic castration-resistant prostate cancer (CRPC), as they prepare to take on rival therapies from Johnson & Johnson and Pfizer/Astellas. The two partners released top-line results from the ARAMIS trial of darolutamide last year, but have now presented the data in full at the ASCO Genitourinary (GU) symposium and published the study in the New England Journal of Medicine . The verdict of the 1,509-patient trial is that darolutamide added to androgen deprivation therapy (ADT) achieved a 59% reduction in the risk of metastasis or death versus ADT plus placebo, with a median metastasis-free survival of 40.4 months compared to 18.4 months, respectively. There was also a trend towards an increase in overall survival of 29% versus placebo, and patients will be monitored in the coming months to see if this develops into a statistically significant improvement. Bayer and Orion say they...

Finasteride Effective in Preventing Prostate Cancer - Targeted Oncology

- February 16, 2019

Ian Thompson, Jr, MD According to the final analysis of the Prostate Cancer Prevention Trial (PCPT), finasteride (Proscar), an agent commonly used to treat lower urinary tract problems and baldness in men, was safe and effective in reducing the risk of prostate cancer. The findings were recently published published in the New England Journal of Medicine . 1 “Finasteride is safe, inexpensive, and effective as a preventive strategy for prostate cancer,” principal investigator Ian Thompson, Jr, MD, chair of SWOG's Genitourinary Cancer committee, and president of CHRISTUS Santa Rosa Hospital Medical Center, said in a press release. “Doctors should share these results with men who get regular prostate-specific antigen (PSA) tests that screen for the presence of prostate cancer. The drug will have its greatest effect in this group of men.” The initial SWOG Cancer Research Network PCPT trial, which was funded by the National Cancer Institute, first opened for enrollmen...

Minimally invasive treatment option for enlarged prostate - PAHomePage.com

- February 28, 2019

Tumor biomarkers for diagnosis, prognosis and targeted therapy | Signal Transduction and Targeted Therapy

- February 13, 2025

signs of gallbladder cancer :: Article Creator 7 Signs You Have Pancreatic Cancer Pancreatic cancer is one of the most challenging cancers to diagnose early because it rarely causes symptoms in its initial stages. By the time symptoms appear, the disease has often advanced significantly, making early detection difficult. However, understanding the warning signs can help individuals seek medical attention sooner, potentially improving outcomes. Fatigue and Physical Weakness Many individuals with pancreatic cancer experience unexplained fatigue and physical weakness, often unrelated to physical exertion. This persistent lack of energy may also be accompanied by difficulty sleeping and feelings of depression. While fatigue is a common symptom of various conditions, its presence alongside other pancreatic cancer symptoms may warrant further investigation. Jaundice and Related Symptoms Jaundice, a condition characterized by yellowing of the...

Iowa News Anchor Showered With Support After Revealing Breast ...

- June 27, 2023

prostate screening :: Article Creator Prostate Cancer Screening And The Golden Rule Of Humanity Takeshi Takahashi, public health physician, former urological surgeon Health and Welfare Bureau, Kitakyushu city office, Jyonai 1-1, Kitakyushu 803-8501, Japan jazzy{at}kuhp.Kyoto-u.Ac.Jp The discussion around prostate cancer screening continues.1 I worked as a urologist for 30 years. When I was young, I hoped only to become an independent urologist and to gain as much surgical experience as possible. But as I approached the target age for prostate specific antigen (PSA) screening, and having heard the opinions of public health experts,23 I could no longer recommend PSA … Senior Living: How To Treat, Prevent Prostate Issues, Including Cancer By Dr. Jennifer Liu, Guest columnist Prostate health is an important issue in aging men. Major health complications can arise from prostate issues, including prostate cancer, decreased quality...

After Beating Cancer Twice, Larry King, 87, Has Died– Legendary Talk Show Host Had Incredible Staying Power - SurvivorNet

- August 18, 2021

Larry King, Hospitalized With COVID-19, Is a Warrior Larry King Live talk show host Larry King, 87, is currently in the hospital fighting COVID-19; he reportedly left the ICU on Sunday. King survived lung cancer in 2017 and prostate cancer in 1999; he has also suffered a stroke and heart disease in the past. For people battling cancer during the COVID-19 pandemic, it's especially important to exercise safety precautions, due to some cancer treatments leading to an immunocompromised state. Legendary TV host and broadcast journalist, Larry King, 87, has spoken of his "indomitable spirit" which allowed him to overcome multiple health issues, including lung cancer in 2017; now, King has passed away from cancer after a battle with COVID. He had previously been treated at Cedars Sinai Medical Center in Los Angeles. And due to safety protocols, it's being reported by CNN that his three sons are not able to visit him in the hospital. Related: A Message on World Lung Cancer D...

Archive

November 20263
October 202632
September 202634
August 202650
July 202656
June 202644
May 202631
April 202658
March 2026111
February 202677

Show more Show less

Labels

"cancer prostata" - Google News
"metastatic prostate cancer" - Google News
"prostate cancer causes" - Google News
"prostate cancer survival rate" - Google News
"prostate cancer treatment options" - Google News
"prostate cancer treatment" - Google News
"prostate cancer" - Google News
"prostatectomy" - Google News
"symptoms of prostate cancer in men" - Google News
cancer+prostata - Google News

Google News
IFTTT
metastatic prostate cancer
metastatic+prostate+cancer - Google News
prostate cancer
prostate cancer causes
prostate cancer survival rate
prostate cancer treatment
prostate cancer treatment options
prostate+cancer - Google News
prostate+cancer+causes - Google News
prostate+cancer+survival+rate - Google News
prostate+cancer+treatment - Google News
prostate+cancer+treatment+options - Google News
prostatectomy
prostatectomy - Google News
symptoms of prostate cancer in men
symptoms+of+prostate+cancer+in+men - Google News

Show more Show less